Tumor-infiltrating T cells as a risk factor for lymph node metastasis in patients with submucosal colorectal cancer.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
06 02 2023
06 02 2023
Historique:
received:
27
09
2022
accepted:
01
02
2023
entrez:
6
2
2023
pubmed:
7
2
2023
medline:
9
2
2023
Statut:
epublish
Résumé
Approximately 10% of patients with colorectal cancer with submucosal invasion have lymph node metastasis. Pathological risk factors for lymph node metastasis have varying sensitivities and specificities. To predict the risk of lymph node metastasis, the identification of new risk factors is vital. Tumor-infiltrating T cells have been reported to improve the prognosis of many solid tumors. Therefore, the purpose of this study was to examine the relationship between lymph node metastasis and tumor-infiltrating T cells in patients with colorectal cancer with submucosal invasion. We examined CD8
Identifiants
pubmed: 36746991
doi: 10.1038/s41598-023-29260-1
pii: 10.1038/s41598-023-29260-1
pmc: PMC9902519
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2077Informations de copyright
© 2023. Crown.
Références
Nat Immunol. 2018 Jun;19(6):538-546
pubmed: 29777219
Crit Rev Oncol Hematol. 2018 Jan;121:11-22
pubmed: 29279096
Science. 2006 Sep 29;313(5795):1960-4
pubmed: 17008531
J Clin Invest. 2010 Apr;120(4):1031-4
pubmed: 20335655
BMC Cancer. 2020 Jun 26;20(1):598
pubmed: 32590956
J Urol. 2015 Aug;194(2):556-62
pubmed: 25752441
Nat Rev Cancer. 2012 Mar 15;12(4):298-306
pubmed: 22419253
Colorectal Dis. 2013 Jul;15(7):788-97
pubmed: 23331927
J Gastroenterol. 2014 Sep;49(9):1314-23
pubmed: 24065123
Br J Cancer. 2017 Aug 8;117(4):451-460
pubmed: 28704840
J Pathol. 2016 Aug;239(4):450-8
pubmed: 27171315
J Gastroenterol Hepatol. 2020 Jun;35(6):1009-1015
pubmed: 31674067
J Immunol. 2007 Mar 1;178(5):2908-15
pubmed: 17312135
Cancer Sci. 2019 Jul;110(7):2080-2089
pubmed: 31102428
Clin Cancer Res. 2014 Apr 15;20(8):2147-58
pubmed: 24523438
Adv Anat Pathol. 2017 Nov;24(6):311-335
pubmed: 28777143
Curr Mol Med. 2009 Sep;9(7):836-50
pubmed: 19860663
Int J Clin Oncol. 2020 Jan;25(1):1-42
pubmed: 31203527
Breast. 2008 Dec;17(6):604-10
pubmed: 18656354
Cell. 2000 May 26;101(5):455-8
pubmed: 10850488
Oncotarget. 2016 May 31;7(22):32902-15
pubmed: 27096956
J Clin Oncol. 2007 Mar 1;25(7):869-75
pubmed: 17327608
J Immunol. 2015 Apr 1;194(7):3475-86
pubmed: 25725111
Annu Rev Immunol. 2011;29:235-71
pubmed: 21219185
Clin Cancer Res. 2010 Aug 15;16(16):4105-12
pubmed: 20682706
Nat Rev Cancer. 2020 Apr;20(4):218-232
pubmed: 32024970
Dig Dis Sci. 2013 Jun;58(6):1581-9
pubmed: 23314859
Clin Cancer Res. 2014 Jan 15;20(2):434-44
pubmed: 24190978
Clin Cancer Res. 2018 Jul 1;24(13):3036-3045
pubmed: 29599411